Liminatus Pharma, Inc.

LIMN ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Profit History

Revenue Operating Income Net Income

Fiscal Year	Revenue	Operating Income	Net Income
FY2024	—	$-3.3M	$-3.5M
FY2025	—	$-3.0M	$-10.2M